Opus Genetics to Present at the Chardan Annual Healthcare Conference
Globe Newswire•13/10/2026•07:00 ET
0
Key Highlights
- ➤Opus Genetics will present at Chardan Annual Healthcare Conference October 20, 2026
- ➤Presentation scheduled for 10:00 a.m. ET
- ➤Pipeline includes seven AAV-based gene therapy programs
RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will present at the Chardan Annual Healthcare Conference on Tuesday, October 20, 2026 at 10:00 a.m. ET.
A link to the live and archived webcast may be accessed on Opus Genetics’ website under the Investors section: Events.
Get started
Create a free account to read the full story.